Last 12 months
Inside the activity.
2 purchase rows · 107 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 26 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2023 Filed Oct 10, 2023 21:36 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 3,498 | $3.02 | $10,563.96 |
DisclosureSEC source: 0000950170-23-052713 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 21:26 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 2,582 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-23-052700 · ownership.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,167 Underlying: Common Stock · 2,582 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 21:26 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 2,582 | $27.24 | $70,333.68 |
DisclosureSEC source: 0000950170-23-052700 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,854 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 21:26 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 2,582 | $11.35 | $29,305.70 |
DisclosureSEC source: 0000950170-23-052700 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 2,418 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-23-051911 · ownership.xml · derivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,418 Underlying: Common Stock · 2,418 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 2,418 | $27.25 | $65,888.81 |
DisclosureSEC source: 0000950170-23-051911 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,854 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $27.24 to $27.28. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 2,418 | $11.35 | $27,444.30 |
DisclosureSEC source: 0000950170-23-051911 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0000950170-23-051909 · ownership.xml · derivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,950 Underlying: Common Stock · 2,200 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $27.32 | $60,104.00 |
DisclosureSEC source: 0000950170-23-051909 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:19 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $5.86 | $12,892.00 |
DisclosureSEC source: 0000950170-23-051909 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 3,031 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-23-051899 · ownership.xml · derivative · entry 5 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,969 Underlying: Common Stock · 3,031 shares Expires 2024-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully exercisable. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC |
Maduck SeanSee Remarks
|
SaleCommon Stock | 3,031 | $27.24 | $82,576.87 |
DisclosureSEC source: 0000950170-23-051899 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,610 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $27.24 to $27.255. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:05 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 3,031 | $3.02 | $9,153.62 |
DisclosureSEC source: 0000950170-23-051899 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 456 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 22:07 UTC |
Maduck SeanSee Remarks
|
SaleCommon Stock | 25,000 | $32.48 | $812,000.00 |
DisclosureSEC source: 0000950170-23-049040 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,610 F2 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $32.32 to $32.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 456 shares underlying unvested restricted stock awards granted to the Reporting Person on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 22:06 UTC |
Robb Gary CharlesChief Business Officer
|
SaleCommon Stock | 5,000 | $32.74 | $163,677.00 |
DisclosureSEC source: 0000950170-23-049039 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,996 F1 · price: Represents the weighted average sale price for entire number of shares sold. The actual sale prices range from $32.72 to $32.79. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. F2 · balance_after: Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 22:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-23-049040 · ownership.xml · derivative · entry 5 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 25,000 shares Expires 2024-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully exercisable. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 22:07 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 25,000 | $3.02 | $75,500.00 |
DisclosureSEC source: 0000950170-23-049040 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 456 shares underlying unvested restricted stock awards granted to the Reporting Person on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 13,963 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000950170-23-048629 · ownership.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 13,963 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
Robb Gary CharlesChief Business Officer
|
Tax withholdingCommon Stock | 7,996 | $33.80 | $270,264.80 |
DisclosureSEC source: 0000950170-23-048629 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,996 F2 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on September 14, 2023. The options subject to the net exercise were to expire on February 18, 2025. F1 · balance_after: Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
Robb Gary CharlesChief Business Officer
|
Exercise / conversionCommon Stock | 13,963 | $3.29 | $45,938.27 |
DisclosureSEC source: 0000950170-23-048629 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 2,200 | $0.00 Strike: $5.86 | $0.00 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · derivative · entry 6 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,150 Underlying: Common Stock · 2,200 shares Expires 2026-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. F2 · balance_after: The reporting person has transferred 50% of certain of his stock options to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 2,200 | $32.90 | $72,380.00 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · nonDerivative · entry 4 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 2,200 | $5.86 | $12,892.00 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · nonDerivative · entry 3 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 1,550 | $0.00 Strike: $6.55 | $0.00 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · derivative · entry 5 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,550 shares Expires 2025-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully exercisable. F2 · balance_after: The reporting person has transferred 50% of certain of his stock options to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
SaleCommon Stock | 1,550 | $32.73 | $50,731.50 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · nonDerivative · entry 2 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 23:04 UTC |
Swisher Daniel N JRDirector
|
Exercise / conversionCommon Stock | 1,550 | $6.55 | $10,152.50 |
DisclosureSEC source: 0000950170-23-046826 · ownership.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:41 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 398 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-046818 · ownership.xml · nonDerivative · entry 2 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,204 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:41 UTC |
Mokari AtabakChief Financial Officer
|
GrantCommon Stock | 398 | $33.10 | $13,173.80 |
DisclosureSEC source: 0000950170-23-046818 · ownership.xml · nonDerivative · entry 1 Mokari Atabak · CIK 0001678419 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,806 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 793 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,260 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,651 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:21 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-23-046814 · ownership.xml · derivative · entry 5 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,167 Underlying: Common Stock · 5,000 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully exercisable. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:21 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
GrantCommon Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 4 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,854 F5 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:21 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
GrantCommon Stock | 361 | $33.10 | $11,949.10 |
DisclosureSEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,493 F3 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023. F4 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:21 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 5,000 | $32.73 | $163,650.00 |
DisclosureSEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,132 F2 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:21 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,000 | $11.35 | $56,750.00 |
DisclosureSEC source: 0000950170-23-046814 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:15 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-046811 · ownership.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,029 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:15 UTC |
Robb Gary CharlesChief Business Officer
|
GrantCommon Stock | 500 | $33.10 | $16,550.00 |
DisclosureSEC source: 0000950170-23-046811 · ownership.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,529 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 1,010 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:06 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-046808 · ownership.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,610 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:06 UTC |
Maduck SeanSee Remarks
|
GrantCommon Stock | 456 | $33.10 | $15,093.60 |
DisclosureSEC source: 0000950170-23-046808 · ownership.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,154 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, 1,460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, and 1,658 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:55 UTC |
Guyer WilliamChief Development Officer
|
GrantCommon Stock | 478 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-046803 · ownership.xml · nonDerivative · entry 2 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,744 F4 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,472 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 21:55 UTC |
Guyer WilliamChief Development Officer
|
GrantCommon Stock | 478 | $33.10 | $15,821.80 |
DisclosureSEC source: 0000950170-23-046803 · ownership.xml · nonDerivative · entry 1 Guyer William · CIK 0001879013 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,266 F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2012 Incentive Award Plan on September 1, 2023. F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. F3 · balance_after: Includes 922 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2022, and 1,472 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| September 01, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
OtherCommon Stock | 1,059 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 18 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 69,693 F2 · kind: Transfer of shares without consideration to the Sean and Molly Maduck Living Trust. F3 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. Read SEC document |
| September 01, 2023 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
GiftCommon Stock | 1,059 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 17 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,929 F1 · balance_after: Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 22:03 UTC |
MAHONEY DAVID LDirector
|
GiftCommon Stock | 34,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-045848 · ownership.xml · nonDerivative · entry 3 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Black Dog Private Foundation Disclosed balance after: 46,147 Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 22:03 UTC |
MAHONEY DAVID LDirector
|
GiftCommon Stock | 34,850 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-045848 · ownership.xml · nonDerivative · entry 2 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Disclosed balance after: 1,169,808 Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 22:03 UTC |
MAHONEY DAVID LDirector
|
GiftCommon Stock | 17,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-045848 · ownership.xml · nonDerivative · entry 1 MAHONEY DAVID L · CIK 0001224091 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust Disclosed balance after: 1,204,658 Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:24 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 833 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000950170-23-043973 · ownership.xml · derivative · entry 5 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,167 Underlying: Common Stock · 833 shares Expires 2029-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:24 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 3,755 | $0.00 Strike: $8.27 | $0.00 |
DisclosureSEC source: 0000950170-23-043973 · ownership.xml · derivative · entry 4 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,755 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:24 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
SaleCommon Stock | 4,588 | $31.19 | $143,099.72 |
DisclosureSEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 3 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,132 F2 · kind: The sales reported in this Form 4 were affected pursuant to Rule 144. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:24 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 833 | $11.35 | $9,454.55 |
DisclosureSEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 2 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 22:24 UTC |
Lyon Joseph DouglasChief Accounting Officer
|
Exercise / conversionCommon Stock | 3,755 | $8.27 | $31,053.85 |
DisclosureSEC source: 0000950170-23-043973 · ownership.xml · nonDerivative · entry 1 Lyon Joseph Douglas · CIK 0001817838 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023 and 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 20:09 UTC |
Hunt HazelChief Scientific Officer
|
SaleCommon Stock | 20,455 | $30.89 | $631,752.68 |
DisclosureSEC source: 0000950170-23-042785 · ownership.xml · nonDerivative · entry 1 Hunt Hazel · CIK 0001698307 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,146 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $30.85 to $30.99. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.